SECUX
Price
$43.94
Change
+$0.39 (+0.90%)
Updated
Jun 22 closing price
Net Assets
74.68M
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

SECUX vs VMGMX

SECUX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
SECUX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SECUX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. SECUX (74.7M). VMGMX pays higher dividends than SECUX: VMGMX (0.62) vs SECUX (0.00). SECUX was incepted earlier than VMGMX: SECUX (57 years) vs VMGMX (15 years). SECUX (1.52) is less costly to investors than VMGMX (0.07). SECUX is a more actively managed with annual turnover of: 144.00 vs. VMGMX (17.00). SECUX has a lower initial minimum investment than VMGMX: SECUX (2500) vs VMGMX (3000). SECUX annual gain was more profitable for investors over the last year : 18.63 vs. VMGMX (12.44). VMGMX return over 5 years is better than : 31.82 vs. SECUX (-12.55).
SECUXVMGMXSECUX / VMGMX
Total Expense Ratio1.520.072,171%
Annual Report Gross Expense Ratio1.520.072,171%
Fund Existence57 years15 years-
Gain YTD14.9999.694155%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets74.7M33.8B0%
Annual Yield % from dividends0.000.62-
Returns for 1 year18.6312.44150%
Returns for 3 years55.3055.17100%
Returns for 5 years-12.5531.82-39%
Returns for 10 years26.43212.4012%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.47N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.11N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.25N/A
N/A
MFS Blended Research Value Equity R4